A Study to Investigate the Pharmacodynamic Effect of Single Doses of MT-8554 in Healthy Subjects

NCT02536209 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: MT-8554 low dose
DRUG: MT-8554 high dose
DRUG: Oxycodone hydrochloride
DRUG: Placebo

Sponsor

Tanabe Pharma Corporation